Dear Applicant,
Thank you for considering Cooper Medical School of Rowan University Hematology and Oncology Fellowship .We are delighted that you are interested in learning more about our program.
Our Hematology/Medical Oncology Fellowship Program aims to provide fellows with comprehensive subspecialty training in benign and malignant hematology, as well as solid tumor oncology through direct clinical experience, both in the inpatient and outpatient setting, and through exposure to clinical research. In this way, our program takes on a true academic approach to the field.
In 2013, Cooper University Health Care partnered with The University of Texas MD Anderson Cancer Center in Houston, Texas – the nation’s leading cancer hospital – to create MD Anderson Cancer Center at Cooper. This partnership is a full clinical integration of the MD Anderson program in Houston. Through this partnership, MD Anderson Cooper physicians adhere to the same processes and guidelines, and patients receive the same proven practice standards and treatment programs provided at MD Anderson. Cooper faculty will have adjunct appointments at MD Anderson and will work closely with the Houston faculty in all aspects of cancer care delivery and research. As a fellow, you will benefit from this relationship by being part of the multidisciplinary focus on cancer care, being exposed to both Cooper and MD Anderson faculty, having access to increasing numbers of MD Anderson clinical trials, and having the opportunity to spend time in Houston on elective rotations.
The clinical experience at MD Anderson Cooper is both diverse and comprehensive. Each year MD Anderson Cooper cares for approximately 3,000 new cancer patients; and as a fellow you will work closely with our 18 physician faculty members as part of disease-site focused multidisciplinary teams. The interaction with other departments and divisions (surgical oncology, radiation oncology, gynecologic oncology, pathology, and diagnostic imaging) is collaborative and strong both clinically and academically.
Our program’s size and structure make it an ideal choice for learning the “art and science” of hematology/medical oncology. In fact, our graduating fellows have obtained a 100 percent first time pass rate for medical oncology and a 95 percent first time pass rate for hematology for the past ten years and have accepted positions at some the of nation’s finest hospitals and private practices.
The majority of our outpatient services are delivered at MD Anderson Cancer Center at Cooper in Camden–a four-story, 100,000 square-foot building dedicated on the main Health Sciences Campus–and at our suburban satellite cancer center in Voorhees, NJ. Inpatient care is provided at our dedicated inpatient oncology unit at Cooper University Hospital.
Please consider a visit to MD Anderson Cancer Center at Cooper and Cooper University Health Care. Don’t hesitate to contact me if there is anything I can do to help you with your selection of a training program. This is one of the most exciting times in your professional career, and we look forward to helping you achieve your professional and personal goals.
Generosa Grana, MD, FACP
Director, MD Anderson Cancer Center at Cooper
Head, Division of Hematology/Medical Oncology, Cooper University Health Care
Professor of Medicine, Cooper Medical School of Rowan University